Functional consequences of iron overload in catecholaminergic interactions: The Youdim factor

被引:10
作者
Archer, Trevor
Fredriksson, Anders
机构
[1] Univ Gothenburg, Dept Psychol, S-45030 Gothenburg, Sweden
[2] Kalmar Univ, Dept Hlth & Behav Sci, Kalmar 391, Sweden
[3] Uppsala Univ, Dept Neurosci & Psychiat, S-75017 Uppsala, Sweden
关键词
iron administration; postnatal; Fe2+; vehicle; clozapine; haloperidol; basal ganglia; motor deficits; locomotion; rearing; total activity; DA D-2; receptor supersensitivity; behavioural deficits;
D O I
10.1007/s11064-007-9358-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The influence of postnatal iron overload upon implications of the functional and interactive role of dopaminergic and noradrenergic pathways that contribute to the expressions of movement disorder and psychotic behaviours in mice was studied in a series of experiments. (1) Postnatal iron overload at doses of 7.5 mg/kg (administered on Days 10-12 post partum) and above, invariably induced a behavioural syndrome consisting of an initial (1st 20-40 min of a 60-min test session) hypoactivity followed by a later (final 20 min of a 60-min test session) hyperactivity, when the mice were tested at adult ages (age 60 days or more). (2) Following postnatal iron overload, subchronic treatment with the neuroleptic compounds, clozapine and haloperidol, dose-dependently reversed the initial hypoactivity and later hyperactivity induced by the metal. Furthermore, DA D-2 receptor supersensitivity (as assessed using the apomorphine-induced behaviour test) was directly and positively correlated with iron concentrations in the basal ganglia. (3) Brain noradrenaline (NA) denervation, using the selective NA neurotoxin, DSP4, prior to administration of the selective DA neurotoxin, MPTP, exacerbated both the functional (hypokinesia) and neurochemical (DA depletion) effects of the latter neurotoxin. Treatment with L-Dopa restored motor activity only in the animals that had not undergone NA denervation. These findings suggest an essential neonatal iron overload, termed "the Youdim factor", directing a DA-NA interactive component in co-morbid disorders of nigrostriatal-limbic brain regions.
引用
收藏
页码:1625 / 1639
页数:15
相关论文
共 104 条
[41]   Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists [J].
Fredriksson, A ;
Palomo, T ;
Chase, T ;
Archer, T .
JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (3-4) :283-300
[42]   MPTP-INDUCED HYPOACTIVITY IN MICE - REVERSAL BY L-DOPA [J].
FREDRIKSSON, A ;
PLAZNIK, A ;
SUNDSTROM, E ;
JONSSON, G ;
ARCHER, T .
PHARMACOLOGY & TOXICOLOGY, 1990, 67 (04) :295-301
[43]   Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period [J].
Fredriksson, A ;
Schröder, N ;
Eriksson, P ;
Izquierdo, I ;
Archer, T .
DEVELOPMENTAL BRAIN RESEARCH, 2000, 119 (01) :65-74
[44]   MPTP-INDUCED BEHAVIORAL AND BIOCHEMICAL DEFICITS - A PARAMETRIC ANALYSIS [J].
FREDRIKSSON, A ;
ARCHER, T .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1994, 7 (02) :123-132
[45]  
FREDRIKSSON A, 1994, STRATEGIES STUDYING, V2, P201
[46]   Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice [J].
Fredriksson, Anders ;
Archer, Trevor .
NEUROTOXICITY RESEARCH, 2006, 10 (02) :123-129
[47]   ALTERED BRAIN METABOLISM OF IRON AS A CAUSE OF NEURODEGENERATIVE DISEASES [J].
GERLACH, M ;
BENSHACHAR, D ;
RIEDERER, P ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1994, 63 (03) :793-807
[48]   REGIONAL STUDIES OF CATECHOLAMINES IN RAT BRAIN .I. DISPOSITION OF [3H]NOREPINEPHRINE [3H]DOPAMINE AND [3H]DOPA IN VARIOUS REGIONS OF BRAIN [J].
GLOWINSKI, J ;
IVERSEN, LL .
JOURNAL OF NEUROCHEMISTRY, 1966, 13 (08) :655-+
[49]   THE EFFECT OF AGE ON THE NON-HAEMIN IRON IN THE HUMAN BRAIN [J].
HALLGREN, B ;
SOURANDER, P .
JOURNAL OF NEUROCHEMISTRY, 1958, 3 (01) :41-51
[50]   QUANTIFICATION OF PRESYNAPTIC ALPHA(2)-ADRENOCEPTORS IN RAT-BRAIN AFTER SHORT-TERM DSP-4 LESIONING [J].
HEAL, DJ ;
BUTLER, SA ;
PROW, MR ;
BUCKETT, WR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (01) :37-41